secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001104659-23-113772
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics closes $5M public offering of stock and warrants
--------------------------------------------------------------------

- Gross proceeds ~$5.0M; estimated net proceeds ~$4.1M after placement agent fees and expenses.
- Offering of 16,633,400 units at $0.3006/unit; each unit has 1 share (or pre-funded warrant) plus two warrants.
- Series A warrants exercisable at $0.3006/share for 5 years; Series B warrants same price for 18 months.
- Maxim Group LLC and Lake Street Capital Markets served as placement agents; 8% cash fee (4% for affiliates).
- Closing occurred November 2, 2023; proceeds expected for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923113772/0001104659-23-113772-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923113772/tm2329202d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-113772

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer